Attorney: FDA Guide On Pregnant Women In Trials Lacks 'Carrots & Sticks'

April 13, 2018
FDA took a first step toward encouraging drug companies to enroll pregnant women in clinical trials by putting out a draft guidance that floats scientific and ethical criteria to guide such enrollment, but an industry lawyer suggests formal market incentives and requirements may be needed before drug makers act expeditiously. However, former FDA commissioner Mark McClellan argues that there are ways to motivate drug makers to include pregnant women that do not require such a “big lift” of legislation. The...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.